Bristol-Myers Squibb (BMY) Announces Presentation of New Opdivo + Yervoy, Immuno-Oncology Data at 2016 STC
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced new data evaluating the combination of Opdivo (nivolumab) plus Yervoy (ipilimumab) and Opdivo plus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
